The case for primary prevention of obesity in the era of GLP-1 therapies

Soren Holm(University of Oslo), Amélie Bonnefond(Centre National de la Recherche Scientifique), Achim Kramer(Charité - Universitätsmedizin Berlin), Alfred Wagtendonk(Vrije Universiteit Amsterdam), Alice Maguolo(University of Verona), Aakruti Kaikini, Adriana Voicu, Agnieszka Kozioł-Kozakowska, Alicia Sicardi(Inserm), Alain Massart(Université d'Orléans), Ainara Cano(Euskadiko Parke Teknologikoa), Adina Weinberger(Weizmann Institute of Science), Torsten Bohn(Luxembourg Institute of Health), Alkyoni Glympi, Paulo J. Oliveira(University of Coimbra), Karl‐Heinz Wagner(University of Vienna), Alvaro Obeso, Agostino Di Ciaula, Dimitrios Koutsouris(Institute of Communication and Computer Systems), Alice Denis, Adrianna Tryskuc, Aleksandra Luszczynska(Czech Academy of Sciences, Institute of Psychology), Alexandros Papadopoulos, Amalia Gastaldelli, Amelia Sarroca, Alexandre Chikalanov, Amaia Barrena, Alexandra Karahaliou, Alexandra Tiganouria, Philippe Froguel(Centre National de la Recherche Scientifique), Adam Selamnia, Afshan Malik, Aikaterina Vasileiou, Sara Arranz(Euskadiko Parke Teknologikoa), Agustin Fernandez, George V. Dedoussis(Harokopio University of Athens), Manuel Tena-Sempere(Instituto Maimónides de Investigación Biomédica de Córdoba), Alexis Kyriacou, Aleksandra Davydova, Alejandra Loyola Leyva, Alessia D'Andrea, Alberto Norhona, Adrian Jauch, Ales Wodecki, Adriana Fontes, Ainhoa Ruano, Jeroen Lakerveld(Vrije Universiteit Amsterdam), Alex Bravo Serrano, Alexia Barroso(Instituto de Salud Carlos III)
The Lancet Regional Health - Europe
April 17, 2026
Cited by 0


Related Papers